I Stock

Summary

Country: Germany

Publications

  1. ncbi Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, University of Bonn, D 53115 Bonn, Germany
    J Antimicrob Chemother 51:865-85. 2003
  2. ncbi Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii, Y. intermedia, Y. kristensenii and Y. rohdei
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, Rheinische Friedrich Wilhelm Universität, Meckenheimer Allee 168, 53115 Bonn, Germany
    FEMS Immunol Med Microbiol 38:139-52. 2003
  3. ncbi [West nile virus. An unusual flavivirus with increased importance]
    Ingo Stock
    , Pharmazeutische Mikrobiologie,
    Med Monatsschr Pharm 27:112-20; quiz 121-2. 2004
  4. ncbi ["New" coronaviruses are the cause of respiratory diseases]
    Ingo Stock
    Med Monatsschr Pharm 29:417. 2006
  5. ncbi [Antimycotic therapy of Tinea pedis and other foot mycoses]
    Ingo Stock
    Med Monatsschr Pharm 31:247-56; quiz 257-8. 2008
  6. ncbi [Infections with Chlamydia trachomatis]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:209-22; quiz 223-4. 2012
  7. ncbi [Special characteristics of antibiotic therapy in the elderly]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:84-92; quiz 93-4. 2012
  8. ncbi [Rubella (German measles)--still a major infectious disease]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:14-22; quiz 23-4. 2012
  9. ncbi [Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease]
    Ingo Stock
    Med Monatsschr Pharm 32:17-26. 2009
  10. ncbi [Human influenza]
    Ingo Stock
    Med Monatsschr Pharm 29:360-8; quiz 369-70. 2006

Collaborators

Detail Information

Publications46

  1. ncbi Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, University of Bonn, D 53115 Bonn, Germany
    J Antimicrob Chemother 51:865-85. 2003
    ..fonticola, also a species-specific class A beta-lactamase. Inducibility of these enzymes was shown in all species with the exception of S. rubidaea and four of five strains of S. plymuthica...
  2. ncbi Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii, Y. intermedia, Y. kristensenii and Y. rohdei
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, Rheinische Friedrich Wilhelm Universität, Meckenheimer Allee 168, 53115 Bonn, Germany
    FEMS Immunol Med Microbiol 38:139-52. 2003
    ..An evaluation of 30 biochemical tests that secured phenotypic identification to the Yersinia species level is presented...
  3. ncbi [West nile virus. An unusual flavivirus with increased importance]
    Ingo Stock
    , Pharmazeutische Mikrobiologie,
    Med Monatsschr Pharm 27:112-20; quiz 121-2. 2004
  4. ncbi ["New" coronaviruses are the cause of respiratory diseases]
    Ingo Stock
    Med Monatsschr Pharm 29:417. 2006
  5. ncbi [Antimycotic therapy of Tinea pedis and other foot mycoses]
    Ingo Stock
    Med Monatsschr Pharm 31:247-56; quiz 257-8. 2008
    ..For systemic treatment, systemically applicable azole antifungals (fluconazole, itraconazole), terbinafine and griseofulvine are in use...
  6. ncbi [Infections with Chlamydia trachomatis]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:209-22; quiz 223-4. 2012
    ..This strategy includes therapeutic and hygienic measures that may be suitable to eliminate one of the leading causes of blindness worldwide...
  7. ncbi [Special characteristics of antibiotic therapy in the elderly]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:84-92; quiz 93-4. 2012
    ..Since older people often take several drugs simultaneously, the probability for the occurrence of side effects and drug interactions in this population is greatly increased. Significant compliance problems may also arise...
  8. ncbi [Rubella (German measles)--still a major infectious disease]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:14-22; quiz 23-4. 2012
    ..Nevertheless, rubella is still widespread in some countries, and still occurs in Germany. Postnatal rubella virus infections can be treated symptomatically. A specific (antiviral) therapy is not available...
  9. ncbi [Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease]
    Ingo Stock
    Med Monatsschr Pharm 32:17-26. 2009
    ..During the last decades, A. albopictus mosquitos have been spread into several temperate regions and are now widely distributed in several areas of South and Central Europe and North America...
  10. ncbi [Human influenza]
    Ingo Stock
    Med Monatsschr Pharm 29:360-8; quiz 369-70. 2006
    ..The virus type of the new pandemic is still uncertain and it is also unclear, if a pandemic spread of the virus may be prevented by consistent controlling of avian influenza...
  11. ncbi [Pertussis--not only a childhood disease]
    Ingo Stock
    Med Monatsschr Pharm 29:206-14; quiz 215-6. 2006
    ..Macrolides are regarded to be the treatment of choice for the management of B. pertussis infections. Active immunization with whole cell and in particular acellular vaccines is the mainstay for prevention of disease...
  12. ncbi [Lymphogranuloma venereum. Expansion of a tropical sexual disease into Europe]
    Ingo Stock
    Med Monatsschr Pharm 29:65-70. 2006
  13. ncbi [Venereal syphilis. "Return" of an old infectious disease]
    Ingo Stock
    Med Monatsschr Pharm 28:338-48; quiz 349-50. 2005
  14. ncbi Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera cryocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 17:143-60. 2005
    ..ascorbata from K. cryocrescens, they do not allow a separation of these species. The literature dealing with the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections is discussed...
  15. ncbi [Illnesses by the human respiratory syncytial virus]
    Ingo Stock
    Med Monatsschr Pharm 29:329-34, 335-6. 2006
    ..Current guidelines do no contain specific recommendations for the causal treatment of HRSV infections. Immunoprophylactic and hygienic measures represent the most effective strategies for prevention of disease...
  16. ncbi Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains
    Ingo Stock
    Pharmaceutical Microbiology, Institute of Medical Microbiology and Immunology, University of Bonn, 53115 Bonn, Germany
    Diagn Microbiol Infect Dis 51:151-63. 2005
    ..albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates...
  17. ncbi [Mumps--infectious disease with various faces]
    Ingo Stock
    Med Monatsschr Pharm 30:249-56; quiz 257-8. 2007
    ..Young adults have been most frequently affected. The lack of immunity in this population is likely to be responsible for the increasing number of mumps cases...
  18. ncbi [Norovirus infections]
    Ingo Stock
    Med Monatsschr Pharm 30:362-70; quiz 371-2. 2007
    ..Because of the high stability of noroviruses to several environmental conditions, disinfection should be performed applying disinfectants with proven activity against noroviruses...
  19. ncbi [Hantavirus infections]
    Ingo Stock
    Med Monatsschr Pharm 31:127-36; quiz 137-8. 2008
    ..In Germany, there is no licensed vaccine applicable for the prevention of hantavirus diseases. Anti-infectious measures are, therefore, regarded to be the most effective strategy to prevent illnesses due to these emerging RNA viruses...
  20. ncbi [Measles]
    Ingo Stock
    Med Monatsschr Pharm 32:118-26; quiz 127-8. 2009
    ....
  21. ncbi [Antimycotic therapy of Tinea unguium and other onychomycoses]
    Ingo Stock
    Med Monatsschr Pharm 32:289-98; quiz 299-300. 2009
    ..An improved effectiveness of systematic treatment is also achieved by concomitant application of topical antifungals...
  22. ncbi [Streptococcus pyogenes--much more than the aetiological agent of scarlet fever]
    Ingo Stock
    Med Monatsschr Pharm 32:408-16; quiz 417-8. 2009
    ..Because of the wide distribution of S. pyogenes in the general population and the lack of an effective vaccine, possibilities for prevention allowing a suitable protection for diseases due to S. pyogenes are very limited...
  23. ncbi [Fungal diseases of vulva and vagina caused by Candida species]
    Ingo Stock
    Med Monatsschr Pharm 33:324-33; quiz 335-6. 2010
    ..Significance of non-conventional and adjuvant therapeutic approaches is considered to be generally low...
  24. ncbi [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 34:234-44; quiz 245-6. 2011
    ..Diagnostics of HIV infection is based upon the proof of specific antibodies...
  25. ncbi [Infections with human immunodeficiency viruses. Part I: pathogens, epidemiology, and clinical presentation]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 34:190-8; quiz 199-200. 2011
    ..In several less developed regions, these so-called AIDS-defining diseases still represent one of the most frequent causes of death...
  26. ncbi [Tuberculosis. An old infectious disease with new problems]
    Ingo Stock
    Med Monatsschr Pharm 28:45-52; quiz 53-4. 2005
  27. ncbi [Treatment for malaria]
    Ingo Stock
    Med Monatsschr Pharm 27:260-72; quiz 273-4. 2004
  28. ncbi Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, D 53115 Bonn, Germany
    Int J Antimicrob Agents 22:35-47. 2003
    ..marcescens aminoglycoside 6'-acetyltransferase AAC(6')-Ic and its absence in other Serratia spp. was supported by the data. All species of the S. liquefaciens complex should be considered as probable agents of human diseases...
  29. ncbi Natural antibiotic susceptibility of Ewingella americana strains
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 15:428-41. 2003
    ..It enlarges the number of Enterobacteriaceae expressing naturally-occurring AmpC beta-lactamases...
  30. ncbi [Rotavirus infections]
    Ingo Stock
    Med Monatsschr Pharm 34:4-13; quiz 15-6. 2011
    ..In Germany, two efficient and secure live vaccines against rotaviruses have been approved. Their application, however, is not generally recommended...
  31. ncbi Antimicrobial susceptibility patterns, beta-lactamases, and biochemical identification of Yokenella regensburgei strains
    Ingo Stock
    Institute of Medical Microbiology and Immunology, University of Bonn, Bonn, Germany
    Diagn Microbiol Infect Dis 48:5-15. 2004
    ..Hydroxyproline amidase, maltosidase, tri-peptidase, proline deaminase, catalase reaction, Voges-Proskauer test, and fermentation of glycerol, melibiose and myo-inositol were suitable parameters to separate Y. regensburgei from H. alvei...
  32. ncbi Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains
    I Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, D 53115 Bonn, Germany
    Clin Microbiol Infect 10:724-33. 2004
    ..Special attention should be paid to biochemically aberrant leclerciae. Apart from biochemical features, fosfomycin susceptibility might be useful to differentiate between L. adecarboxylata and E. coli...
  33. ncbi Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 15:12-26. 2003
    ..Natural susceptibility patterns are compared with those of a recent study, dealing with natural susceptibilities of species of the P. vulgaris complex...
  34. ncbi Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, University of Bonn, Meckenheimer Allee 168, D 53115 Bonn, Germany
    J Antimicrob Chemother 48:803-11. 2001
    ..A database is described of the natural susceptibility of P. shigelloides strains to a wide range of antibiotics. It can be used for the validation of susceptibility test results of these bacteria...
  35. ncbi Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, D 53115, Bonn, Germany
    Int J Antimicrob Agents 18:537-45. 2001
    ..Enterobacter hormaechei was the species most susceptible to fosfomycin. beta-Lactam susceptibility patterns pointed to the presence of chromosomally-encoded AmpC enzymes in all taxa of the E. cloacae complex...
  36. ncbi Natural antibiotic susceptibility of Enterobacter spp., with special reference to Enterobacter aerogenes and Enterobacter intermedius strains
    I Stock
    Rheinische Friedrich Wilhelm Universität, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 14:444-60. 2002
    ..The naturally-expressed amount of enzyme depends on the species...
  37. ncbi Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae
    I Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany
    Antimicrob Agents Chemother 45:2245-55. 2001
    ..The present study describes a database concerning the natural susceptibility of Edwardsiella species to a wide range of antibiotics, which can be applied to validate forthcoming antibiotic susceptibility tests of these microorganisms...
  38. ncbi Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains
    I Stock
    Pharmaceutical Microbiology, University of Bonn, Germany
    J Chemother 12:30-9. 2000
    ..Under the conditions described pyrase might be a parameter to differentiate strains of Rahnella genomovars 1 and 2...
  39. ncbi Natural antibiotic susceptibility of Salmonella enterica strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, D 53115, Bonn, Germany
    Int J Antimicrob Agents 16:211-7. 2000
    ..A database of the antibiotic susceptibility of S. enterica was set up. It may be of use to validate antibiotic susceptibility test results of these bacteria...
  40. ncbi Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Germany
    J Med Microbiol 50:396-406. 2001
    ..pneumoniae. Similar natural susceptibility patterns of K. planticola and K. ornithinolytica to all tested antibiotics support the status of K. ornithinolytica as a biovar of K. planticola...
  41. ncbi Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains
    I Stock
    Universitat Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, D 53115 Bonn, Germany
    Clin Microbiol Infect 8:564-78. 2002
    ..To investigate the natural susceptibility to 69 antimicrobial agents of 107 Enterobacter strains comprising E. amnigenus (n = 18), E. cancerogenus (n = 26), E. gergoviae (n = 28) and E. sakazakii (n = 35)...
  42. ncbi Moellerella wisconsensis: identification, natural antibiotic susceptibility and its dependency on the medium applied
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany
    Diagn Microbiol Infect Dis 45:1-11. 2003
    ..From the data of the present study it is possible that some moellerellae are misidentified as Klebsiella pneumoniae subsp. ozaenae...
  43. ncbi [Coronaviruses. Causes of SARS and other infections]
    Ingo Stock
    , Pharmazeutische Mikrobiologie, , Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 27:4-12. 2004
  44. ncbi Biochemical and genetic characterization of the beta-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and "Y. ruckeri" strains
    Andrea Maria Schiefer
    , , Pharmazeutische Mikrobiologie, Bonn, Germany
    Int J Antimicrob Agents 25:496-500. 2005
    ..Beta-lactamases of Y. aldovae and "Y. ruckeri" have been characterized for the first time...
  45. ncbi beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium
    I Stock
    Pharmazeutische Mikrobiologie, , Germany
    Scand J Infect Dis 33:692-6. 2001
    ..The potential to be resistant to a variety of beta-lactams under conceivable testing conditions should question the use of numerous beta-lactams for the treatment of Plesiomonas infections...
  46. ncbi Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri'
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Germany
    J Med Microbiol 51:56-69. 2002
    ..aldovae and 'Y. ruckeri' strains express no, or only small amounts, of enzyme. An evaluation of 30 biochemical tests that determined phenotypic identification to the Yersinia species level is presented...